Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial

por Harandi, A. A., Abolfazli, R., Hatemian, A., Ghragozlee, K., Ghaffar-Pour, M., Karimi, M., Shahbegi, S., Pakdaman, H., Tabasi, M., Tabatabae, A. L., Nourian, A.
Publicado 2011